EnBio Holdings, Inc (TYO:6092)
Japan · Delayed Price · Currency is JPY 612.00
-20.00 (-3.16%)
At close: Feb 13, 2026
EnBio Holdings Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 10,392 | 10,668 | 9,575 | 8,120 | 8,987 | 6,840 | |
Revenue Growth (YoY) | 3.38% | 11.42% | 17.92% | -9.65% | 31.39% | -7.67% |
Cost of Revenue | 7,718 | 8,014 | 7,092 | 5,355 | 6,562 | 4,950 |
Gross Profit | 2,674 | 2,654 | 2,483 | 2,765 | 2,425 | 1,890 |
Selling, General & Admin | 1,950 | 1,814 | 1,668 | 1,407 | 1,196 | 1,165 |
Other Operating Expenses | - | - | - | - | - | 107 |
Operating Expenses | 1,942 | 1,806 | 1,667 | 1,407 | 1,181 | 1,272 |
Operating Income | 732 | 848 | 816 | 1,358 | 1,244 | 618 |
Interest Expense | -164 | -141 | -114 | -124 | -123 | -125 |
Interest & Investment Income | 61 | 60 | 45 | 36 | 25 | 10 |
Currency Exchange Gain (Loss) | 82 | -27 | 186 | 65 | 80 | 17 |
Other Non Operating Income (Expenses) | -51 | -39 | 133 | 8 | -30 | 73 |
EBT Excluding Unusual Items | 660 | 701 | 1,066 | 1,343 | 1,196 | 593 |
Gain (Loss) on Sale of Assets | - | - | - | - | -2 | 11 |
Asset Writedown | -9 | -9 | -12 | -110 | -95 | -116 |
Other Unusual Items | 9 | 9 | 10 | - | -1 | - |
Pretax Income | 898 | 701 | 1,064 | 1,233 | 1,098 | 488 |
Income Tax Expense | 347 | 281 | 326 | 437 | 392 | 157 |
Earnings From Continuing Operations | 551 | 420 | 738 | 796 | 706 | 331 |
Minority Interest in Earnings | 29 | 32 | -30 | 16 | -52 | -27 |
Net Income | 580 | 452 | 708 | 812 | 654 | 304 |
Net Income to Common | 580 | 452 | 708 | 812 | 654 | 304 |
Net Income Growth | -27.68% | -36.16% | -12.81% | 24.16% | 115.13% | -45.23% |
Shares Outstanding (Basic) | 8 | 8 | 8 | 7 | 7 | 7 |
Shares Outstanding (Diluted) | 8 | 8 | 8 | 7 | 7 | 7 |
Shares Change (YoY) | -0.42% | 1.52% | 20.11% | -0.01% | -0.03% | 0.07% |
EPS (Basic) | 71.68 | 55.81 | 88.75 | 122.26 | 98.52 | 46.21 |
EPS (Diluted) | 71.68 | 55.81 | 88.75 | 122.26 | 98.47 | 45.76 |
EPS Growth | -27.37% | -37.11% | -27.41% | 24.16% | 115.19% | -45.29% |
Free Cash Flow | -365 | -1,441 | 584 | 827 | 1,249 | -1,432 |
Free Cash Flow Per Share | -45.11 | -177.93 | 73.21 | 124.52 | 188.04 | -215.52 |
Dividend Per Share | 9.000 | 9.000 | 8.000 | 8.000 | 8.000 | - |
Dividend Growth | 12.50% | 12.50% | - | - | - | - |
Gross Margin | 25.73% | 24.88% | 25.93% | 34.05% | 26.98% | 27.63% |
Operating Margin | 7.04% | 7.95% | 8.52% | 16.72% | 13.84% | 9.04% |
Profit Margin | 5.58% | 4.24% | 7.39% | 10.00% | 7.28% | 4.44% |
Free Cash Flow Margin | -3.51% | -13.51% | 6.10% | 10.18% | 13.90% | -20.94% |
EBITDA | 1,257 | 1,345 | 1,254 | 1,758 | 1,585 | 985 |
EBITDA Margin | 12.10% | 12.61% | 13.10% | 21.65% | 17.64% | 14.40% |
D&A For EBITDA | 525 | 497 | 438 | 400 | 341 | 367 |
EBIT | 732 | 848 | 816 | 1,358 | 1,244 | 618 |
EBIT Margin | 7.04% | 7.95% | 8.52% | 16.72% | 13.84% | 9.04% |
Effective Tax Rate | 38.64% | 40.09% | 30.64% | 35.44% | 35.70% | 32.17% |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.